Skip to content

CORMEDIX INC.: 10-Q filed 2020-08-10

What CORMEDIX INC. reported in its quarterly report filed 2020-08-10 (fiscal Q2 2020): 40 published measures, 110 facts as tagged in accession 0001213900-20-021151.

This filing

Form
10-Q (quarterly report)
Filed
2020-08-10
Fiscal period
fiscal Q2 2020
Accession
0001213900-20-021151 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All CORMEDIX INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2020-06-3024,237,239USD
At 2019-12-3129,475,910USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2020-06-305,715,769USD
At 2019-12-315,829,650USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2020-06-3018,521,470USD
At 2020-03-3121,593,450USD
At 2019-12-3123,646,260USD
At 2019-06-3016,475,051USD
At 2019-03-3116,541,965USD
At 2018-12-314,934,256USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2020-06-3016,493,967USD
At 2019-12-3116,350,237USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2020-04-01 to 2020-06-30-3,782,424USD91
2020-01-01 to 2020-06-30-9,339,991USD182
2019-04-01 to 2019-06-30-696,158USD91
2019-01-01 to 2019-06-30-5,864,042USD181

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2020-01-01 to 2020-06-30-8,721,295USD182
2019-01-01 to 2019-06-30-7,203,015USD181

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2020-01-01 to 2020-06-3013,955USD182
2019-01-01 to 2019-06-3022,725USD181

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2020-04-01 to 2020-06-3016,443USD91
2020-01-01 to 2020-06-3090,498USD182
2019-04-01 to 2019-06-3035,266USD91
2019-01-01 to 2019-06-30198,958USD181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2020-01-01 to 2020-06-302,834,664USD182
2019-01-01 to 2019-06-3015,981,357USD181

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2020-01-01 to 2020-06-306,030,389USD182
2019-01-01 to 2019-06-30-11,839,528USD181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2020-06-30-204,761,163USD
At 2019-12-31-195,421,172USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2020-04-01 to 2020-06-30-5,169,395USD91
2020-01-01 to 2020-06-30-5,169,395USD182
2019-04-01 to 2019-06-30-5,060,778USD91
2019-01-01 to 2019-06-30-5,060,778USD181

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2020-06-30102,836USD
At 2019-12-31126,820USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2020-01-01 to 2020-06-301,372,204USD182
2019-01-01 to 2019-06-301,415,662USD181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2020-04-01 to 2020-06-30-8,920,609USD91
2020-01-01 to 2020-06-30-14,532,358USD182
2019-04-01 to 2019-06-30-5,537,356USD91
2019-01-01 to 2019-06-30-10,460,537USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2020-06-3024,134,403USD
At 2019-12-3129,349,090USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2020-04-01 to 2020-06-3013,828USD91
2020-01-01 to 2020-06-3020,104USD182
2019-04-01 to 2019-06-30306,736USD91
2019-01-01 to 2019-06-30608,783USD181

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2020-06-305,713,942USD
At 2019-12-315,826,972USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2020-06-301,385,909USD
At 2019-12-311,024,280USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2020-04-01 to 2020-06-308,917,868USD91
2020-01-01 to 2020-06-3014,555,155USD182
2019-04-01 to 2019-06-305,551,494USD91
2019-01-01 to 2019-06-3010,411,412USD181

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2020-06-30277,835USD
At 2019-12-31338,465USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2020-04-01 to 2020-06-30-2,741USD91
2020-01-01 to 2020-06-3022,797USD182
2019-04-01 to 2019-06-3014,138USD91
2019-01-01 to 2019-06-30-49,125USD181

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2020-04-01 to 2020-06-3019,184USD91
2020-01-01 to 2020-06-3067,701USD182
2019-04-01 to 2019-06-3021,128USD91
2019-01-01 to 2019-06-30248,083USD181

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2020-04-01 to 2020-06-303,232,576USD91
2020-01-01 to 2020-06-306,397,747USD182
2019-04-01 to 2019-06-302,571,587USD91
2019-01-01 to 2019-06-304,556,509USD181

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2020-04-01 to 2020-06-305,685,292USD91
2020-01-01 to 2020-06-308,157,408USD182
2019-04-01 to 2019-06-302,979,907USD91
2019-01-01 to 2019-06-305,854,903USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2020-06-3026,127,379shares
At 2019-12-3125,665,350shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2020-06-3016,669,127USD
At 2019-12-3116,525,187USD
At 2019-06-3014,733,383USD
At 2018-12-3117,795,323USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2020-06-30223,150,674USD
At 2019-12-31218,944,268USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2020-06-30105,590USD
At 2019-12-3197,257USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2020-06-303,000USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2020-06-304,328,033USD
At 2019-12-314,800,486USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2020-06-301,128,755USD
At 2019-12-31446,415USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2020-04-01 to 2020-06-30-8,951,819USD91
2020-01-01 to 2020-06-30-14,509,386USD182
2019-04-01 to 2019-06-30-5,756,936USD91
2019-01-01 to 2019-06-30-10,924,820USD181

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2020-04-01 to 2020-06-30-3,767,570USD91
2020-01-01 to 2020-06-30-9,331,658USD182
2019-04-01 to 2019-06-30-687,027USD91
2019-01-01 to 2019-06-30-5,856,224USD181

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2020-01-01 to 2020-06-3037,087USD182
2019-01-01 to 2019-06-3040,470USD181

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2020-04-01 to 2020-06-30-31,210USD91
2020-01-01 to 2020-06-3022,972USD182
2019-04-01 to 2019-06-30-219,580USD91
2019-01-01 to 2019-06-30-464,283USD181

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2020-01-01 to 2020-06-3020,104USD182

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2020-01-01 to 2020-06-302,469,937USD182
2019-01-01 to 2019-06-3015,234,529USD181

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2020-01-01 to 2020-06-30-49,532USD182
2019-01-01 to 2019-06-30-25,801USD181

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2020-01-01 to 2020-06-30361,508USD182
2019-01-01 to 2019-06-30-1,682,752USD181

Inspect the source

Entity
CORMEDIX INC. / CIK 0001410098
Captured
2026-09-20T08:01:45.168Z
SEC response SHA-256
b75757faacc84388fbe591a3ec2593969ffefe3c9ea86056a188a6fcb0c2f8bb

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001410098.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))